0001820379-22-000001.txt : 20220111 0001820379-22-000001.hdr.sgml : 20220111 20220111134401 ACCESSION NUMBER: 0001820379-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 EFFECTIVENESS DATE: 20220111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Validus Cellular Therapeutics, Inc. CENTRAL INDEX KEY: 0001820379 IRS NUMBER: 843607605 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-428819 FILM NUMBER: 22523489 BUSINESS ADDRESS: STREET 1: 12635 E MONTVIEW BLVD. STREET 2: SUITE 100 CITY: AURORA STATE: CO ZIP: 80045 BUSINESS PHONE: 720-767-0350 MAIL ADDRESS: STREET 1: 12635 E MONTVIEW BLVD. STREET 2: SUITE 100 CITY: AURORA STATE: CO ZIP: 80045 D 1 primary_doc.xml X0708 D LIVE 0001820379 Validus Cellular Therapeutics, Inc. 12635 E MONTVIEW BLVD. SUITE 100 AURORA CO COLORADO 80045 720-767-0350 DELAWARE None None Corporation true 2019 Mike Handley 12635 E. Montview Blvd. Aurora CO COLORADO 80045 Director Ethan Mann 12635 E. Montview Blvd. Aurora CO COLORADO 80045 Executive Officer Director Steven Dow 12635 E. Montview Blvd. Aurora CO COLORADO 80045 Director Frank Barry 12635 E. Montview Blvd. Aurora CO COLORADO 80045 Director Other Technology Decline to Disclose 06b false 2021-11-09 false true true false 0 2000000 25000 1975000 The total offering amount is for convertible promissory notes, convertible into shares of the company's capital stock. Investors also receive a warrant to purchase shares of the company's capital stock. false 1 0 0 0 false Validus Cellular Therapeutics, Inc. /s/ Tyler Hayden Tyler Hayden Attorney-in-Fact 2022-01-11